103 related articles for article (PubMed ID: 12921955)
1. Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia.
Cheong JW; Eom JI; Maeng HY; Lee ST; Hahn JS; Ko YW; Min YH
Leuk Res; 2003 Dec; 27(12):1159-62. PubMed ID: 12921955
[TBL] [Abstract][Full Text] [Related]
2. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome.
Cheong JW; Eom JI; Maeng HY; Lee ST; Hahn JS; Ko YW; Min YH
Br J Haematol; 2003 Aug; 122(3):454-6. PubMed ID: 12877673
[TBL] [Abstract][Full Text] [Related]
3. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
Li P; Lee H; Guo S; Unterman TG; Jenster G; Bai W
Mol Cell Biol; 2003 Jan; 23(1):104-18. PubMed ID: 12482965
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
Min YH; Cheong JW; Kim JY; Eom JI; Lee ST; Hahn JS; Ko YW; Lee MH
Cancer Res; 2004 Aug; 64(15):5225-31. PubMed ID: 15289327
[TBL] [Abstract][Full Text] [Related]
5. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
7. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
[TBL] [Abstract][Full Text] [Related]
8. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
Rena G; Prescott AR; Guo S; Cohen P; Unterman TG
Biochem J; 2001 Mar; 354(Pt 3):605-12. PubMed ID: 11237865
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.
Guo S; Rena G; Cichy S; He X; Cohen P; Unterman T
J Biol Chem; 1999 Jun; 274(24):17184-92. PubMed ID: 10358076
[TBL] [Abstract][Full Text] [Related]
10. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1.
Medema RH; Kops GJ; Bos JL; Burgering BM
Nature; 2000 Apr; 404(6779):782-7. PubMed ID: 10783894
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR.
Ramaswamy S; Nakamura N; Sansal I; Bergeron L; Sellers WR
Cancer Cell; 2002 Jul; 2(1):81-91. PubMed ID: 12150827
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.
Ghatak S; Misra S; Toole BP
J Biol Chem; 2002 Oct; 277(41):38013-20. PubMed ID: 12145277
[TBL] [Abstract][Full Text] [Related]
13. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.
Daitoku H; Yamagata K; Matsuzaki H; Hatta M; Fukamizu A
Diabetes; 2003 Mar; 52(3):642-9. PubMed ID: 12606503
[TBL] [Abstract][Full Text] [Related]
14. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.
Nakamura N; Ramaswamy S; Vazquez F; Signoretti S; Loda M; Sellers WR
Mol Cell Biol; 2000 Dec; 20(23):8969-82. PubMed ID: 11073996
[TBL] [Abstract][Full Text] [Related]
15. Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via phosphatidylinositol 3-kinase in porcine granulosa cells.
Cunningham MA; Zhu Q; Unterman TG; Hammond JM
Endocrinology; 2003 Dec; 144(12):5585-94. PubMed ID: 12960025
[TBL] [Abstract][Full Text] [Related]
16. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
[TBL] [Abstract][Full Text] [Related]
17. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells.
Mazumdar A; Kumar R
FEBS Lett; 2003 Jan; 535(1-3):6-10. PubMed ID: 12560069
[TBL] [Abstract][Full Text] [Related]
18. Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcription factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription.
Tomizawa M; Kumar A; Perrot V; Nakae J; Accili D; Rechler MM
J Biol Chem; 2000 Mar; 275(10):7289-95. PubMed ID: 10702299
[TBL] [Abstract][Full Text] [Related]
19. Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable.
Min YH; Eom JI; Cheong JW; Maeng HO; Kim JY; Jeung HK; Lee ST; Lee MH; Hahn JS; Ko YW
Leukemia; 2003 May; 17(5):995-7. PubMed ID: 12750723
[No Abstract] [Full Text] [Related]
20. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.
Modur V; Nagarajan R; Evers BM; Milbrandt J
J Biol Chem; 2002 Dec; 277(49):47928-37. PubMed ID: 12351634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
